Dercum’s Disease Market Research Report Information by Treatment (Surgery, Medication {Diuretics, Non-Steroidal Anti-Inflammatory Drug, Corticosteroids, and Others}, Liposuction, Electrotherapy, Acupuncture, and Others) by End user (Hospital & Clinics, Ambulatory Surgical Centers, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 LIST OF ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS

3.4 FORECASTING TECHNIQUES

3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.5.1 BOTTOM-UP APPROACH

3.5.2 TOP-DOWN APPROACH

3.6 DATA TRIANGULATION

3.7 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISING PREVALENCE OF RARE DISEASES

4.2.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES

4.3 RESTRAINTS

4.3.1 LACK OF AWARENESS AMONG THE PEOPLE ABOUT THE DISEASE

4.4 OPPORTUNITIES

4.4.1 RISING NUMBER OF STRATEGIC INITIATIVES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 SALES AND DISTRIBUTION

5.1.4 POST-SALES REVIEW

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL DERCUM’S DISEASE MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON DEMAND

5.3.3 IMPACT ON MARKET

6 GLOBAL DERCUM’S DISEASE MARKET, BY TREATMENT

6.1 OVERVIEW

6.2 SURGERY

6.3 MEDICATION

6.3.1 DIURETICS

6.3.2 NON-STEROIDAL ANTI-INFLAMMATORY DRUG

6.3.3 CORTICOSTEROIDS

6.3.4 OTHERS

6.4 LIPOSUCTION

6.5 ELECTROTHERAPY

6.6 ACUPUNCTURE

6.7 OTHERS

7 GLOBAL DERCUM’S DISEASE MARKET, BY END-USER

7.1 OVERVIEW

7.2 HOSPITAL & CLINICS

7.3 AMBULATORY SURGICAL CENTERS

7.4 OTHERS

8 GLOBAL DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL

8.1 OVERVIEW

8.2 HOSPITAL PHARMACIES

8.3 RETAIL PHARMACIES

8.4 OTHERS

9 GLOBAL DERCUM’S DISEASE MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 UK

9.3.3 FRANCE

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA PACIFIC

9.4.1 CHINA

9.4.2 INDIA

9.4.3 INDIA

9.4.4 AUSTRALIA

9.4.5 SOUTH KOREA

9.4.6 REST OF ASIA PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST

9.5.2 AFRICA

9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 FINANCIAL MATRIX

10.3.1 SALES (USD MILLION), 2022

10.3.2 R&D EXPENDITURE (USD MILLION), 2022

11 COMPANY PROFILES

11.1 PFIZER INC

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 ABBVIE, INC

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 KEY STRATEGIES

11.3 JOHNSON & JOHNSON SERVICES, INC

11.3.1 COMPANY OVERVIEWS

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 GLAXOSMITHKLINE PLC

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.4.6 KEY STRATEGIES

11.5 BAUSCH & LOMB INCORPORATED

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTSS

11.5.5 KEY STRATEGIES

11.6 CALIWAY

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS/SERVICES OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 KEY STRATEGIES

11.7 RAZIEL THERAPEUTICS LTD

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 KEY STRATEGIES

11.8 NIVARTA, INC.

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.8.6 KEY STRATEGIES

11.9 BHR PHARMACEUTICALS LTD

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY STRATEGIES

11.10 NOVARTIS INTERNATIONAL AG

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 SWOT ANALYSIS

11.10.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 GLOBAL: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032 (USD MILLION)

TABLE 3 GLOBAL: DERCUM’S DISEASE MARKET, FOR SURGERY, BY REGION, 2019–2032 (USD MILLION)

TABLE 4 GLOBAL: DERCUM’S DISEASE MARKET, FOR MEDICATION, BY REGION, 2019–2032 (USD MILLION)

TABLE 5 GLOBAL: DERCUM’S DISEASE MARKET, FOR MEDICATION, BY TYPE, 2019–2032 (USD MILLION)

TABLE 6 GLOBAL: DERCUM’S DISEASE MARKET, FOR DIURETICS, BY REGION, 2019–2032 (USD MILLION)

TABLE 7 GLOBAL: DERCUM’S DISEASE MARKET, FOR NON-STEROIDAL ANTI-INFLAMMATORY DRUG, BY REGION, 2019–2032 (USD MILLION)

TABLE 8 GLOBAL: DERCUM’S DISEASE MARKET, FOR CORTICOSTEROIDS, BY REGION, 2019–2032 (USD MILLION)

TABLE 9 GLOBAL: DERCUM’S DISEASE MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 10 GLOBAL: DERCUM’S DISEASE MARKET, FOR LIPOSUCTION, BY REGION, 2019–2032 (USD MILLION)

TABLE 11 GLOBAL: DERCUM’S DISEASE MARKET, FOR ELECTROTHERAPY, BY REGION, 2019–2032 (USD MILLION)

TABLE 12 GLOBAL: DERCUM’S DISEASE MARKET, FOR ACUPUNCTURE, BY REGION, 2019–2032 (USD MILLION)

TABLE 13 GLOBAL: DERCUM’S DISEASE MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 14 GLOBAL: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032 (USD MILLION)

TABLE 15 GLOBAL: DERCUM’S DISEASE MARKET, FOR HOSPITAL & CLINICS, BY REGION, 2019–2032 (USD MILLION)

TABLE 16 GLOBAL: DERCUM’S DISEASE MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 17 GLOBAL: DERCUM’S DISEASE MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 18 GLOBAL: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)

TABLE 19 GLOBAL: DERCUM’S DISEASE MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019–2032 (USD MILLION)

TABLE 20 GLOBAL: DERCUM’S DISEASE MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019–2032 (USD MILLION)

TABLE 21 GLOBAL: DERCUM’S DISEASE MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 22 GLOBAL: DERCUM’S DISEASE MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 23 NORTH AMERICA: DERCUM’S DISEASE MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 24 NORTH AMERICA: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032 (USD MILLION)

TABLE 25 NORTH AMERICA: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032 (USD MILLION)

TABLE 26 NORTH AMERICA: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032 (USD MILLION)

TABLE 27 NORTH AMERICA: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)

TABLE 28 US: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032 (USD MILLION)

TABLE 29 US: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032 (USD MILLION)

TABLE 30 US: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032 (USD MILLION)

TABLE 31 US: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)

TABLE 32 CANADA: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032 (USD MILLION)

TABLE 33 CANADA: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032 (USD MILLION)

TABLE 34 CANADA: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032 (USD MILLION)

TABLE 35 CANADA: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)

TABLE 36 EUROPE: DERCUM’S DISEASE MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 37 EUROPE: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032 (USD MILLION)

TABLE 38 EUROPE: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032 (USD MILLION)

TABLE 39 EUROPE: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032 (USD MILLION)

TABLE 40 EUROPE: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)

TABLE 41 GERMANY: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032 (USD MILLION)

TABLE 42 GERMANY: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032 (USD MILLION)

TABLE 43 GERMANY: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032 (USD MILLION)

TABLE 44 GERMANY: DERCUM’S DISEASE MARKET, BY DISTRIBUTIONCHANNEL, 2019–2032 (USD MILLION)

TABLE 45 UK: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032 (USD MILLION)

TABLE 46 UK: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032 (USD MILLION)

TABLE 47 UK: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032 (USD MILLION)

TABLE 48 UK: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)

TABLE 49 FRANCE: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032 (USD MILLION)

TABLE 50 FRANCE: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032 (USD MILLION)

TABLE 51 FRANCE: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032 (USD MILLION)

TABLE 52 FRANCE: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)

TABLE 53 ITALY: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032 (USD MILLION)

TABLE 54 ITALY: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032 (USD MILLION)

TABLE 55 ITALY: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032 (USD MILLION)

TABLE 56 ITALY: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)

TABLE 57 SPAIN: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032 (USD MILLION)

TABLE 58 SPAIN: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032 (USD MILLION)

TABLE 59 SPAIN: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032 (USD MILLION)

TABLE 60 SPAIN: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)

TABLE 61 REST OF EUROPE: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032 (USD MILLION)

TABLE 62 REST OF EUROPE: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032 (USD MILLION)

TABLE 63 REST OF EUROPE: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032 (USD MILLION)

TABLE 64 REST OF EUROPE: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)

TABLE 65 ASIA PACIFIC: DERCUM’S DISEASE MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 66 ASIA PACIFIC: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032(USD MILLION)

TABLE 67 ASIA PACIFIC: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032(USD MILLION)

TABLE 68 ASIA PACIFIC: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032(USD MILLION)

TABLE 69 ASIA PACIFIC: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032(USD MILLION)

TABLE 70 CHINA: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032(USD MILLION)

TABLE 71 CHINA: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032(USD MILLION)

TABLE 72 CHINA: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032(USD MILLION)

TABLE 73 CHINA: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032(USD MILLION)

TABLE 74 INDIA: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032(USD MILLION)

TABLE 75 INDIA: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032(USD MILLION)

TABLE 76 INDIA: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032(USD MILLION)

TABLE 77 CHINA: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032(USD MILLION)

TABLE 78 JAPAN: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032(USD MILLION)

TABLE 79 JAPAN: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032(USD MILLION)

TABLE 80 JAPAN: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032(USD MILLION)

TABLE 81 JAPAN: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032(USD MILLION)

TABLE 82 AUSTRALIA: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032(USD MILLION)

TABLE 83 AUSTRALIA: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032(USD MILLION)

TABLE 84 AUSTRALIA: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032(USD MILLION)

TABLE 85 AUSTRALIA: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032(USD MILLION)

TABLE 86 SOUTH KOREA: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032(USD MILLION)

TABLE 87 SOUTH KOREA: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032(USD MILLION)

TABLE 88 SOUTH KOREA: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032(USD MILLION)

TABLE 89 SOUTH KOREA: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032(USD MILLION)

TABLE 90 REST OF ASIA PACIFIC: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032(USD MILLION)

TABLE 91 REST OF ASIA PACIFIC: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032(USD MILLION)

TABLE 92 REST OF ASIA PACIFIC: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032(USD MILLION)

TABLE 93 REST OF ASIA PACIFIC: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032(USD MILLION)

TABLE 94 REST OF THE WORLD: DERCUM’S DISEASE MARKET, BY REGION, 2019–2032(USD MILLION)

TABLE 95 REST OF THE WORLD: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032(USD MILLION)

TABLE 96 REST OF THE WORLD: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032(USD MILLION)

TABLE 97 REST OF THE WORLD: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032(USD MILLION)

TABLE 98 REST OF THE WORLD: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032(USD MILLION)

TABLE 99 MIDDLE EAST: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032(USD MILLION)

TABLE 100 MIDDLE EAST: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032(USD MILLION)

TABLE 101 MIDDLE EAST: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032(USD MILLION)

TABLE 102 MIDDLE EAST: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032(USD MILLION)

TABLE 103 AFRICA: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032(USD MILLION)

TABLE 104 AFRICA: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032(USD MILLION)

TABLE 105 AFRICA: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032(USD MILLION)

TABLE 106 AFRICA: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032(USD MILLION)

TABLE 107 LATIN AMERICA: DERCUM’S DISEASE MARKET, BY TREATMENT, 2019–2032(USD MILLION)

TABLE 108 LATIN AMERICA: DERCUM’S DISEASE MARKET, BY MEDICATION, 2019–2032(USD MILLION)

TABLE 109 LATIN AMERICA: DERCUM’S DISEASE MARKET, BY END-USER, 2019–2032(USD MILLION)

TABLE 110 LATIN AMERICA: DERCUM’S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032(USD MILLION)

TABLE 111 MAJOR PLAYERS IN THE GLOBAL DERCUM’S DISEASE MARKET

TABLE 112 PFIZER INC: PRODUCTS OFFERED

TABLE 113 ABBVIE, INC: PRODUCTS OFFERED

TABLE 114 JOHNSON & JOHNSON SERVICES, INC: PRODUCTS OFFERED

TABLE 115 GLAXOSMITHKLINE PLC: PRODUCTS OFFERED

TABLE 116 BAUSCH & LOMB INCORPORATED: PRODUCTS OFFERED

TABLE 117 3M: PRODUCTS/SERVICES OFFERED

TABLE 118 RAZIEL THERAPEUTICS LTD: PRODUCTS OFFERED

TABLE 119 NIVARTA, INC: PRODUCTS OFFERED

TABLE 120 BHR PHARMACEUTICALS LTD: PRODUCTS OFFERED

TABLE 121 NOVARTIS INTERNATIONAL AG: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL DERCUM’S DISEASE MARKET STRUCTURE

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL DERCUM’S DISEASE MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL DERCUM’S DISEASE MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DERCUM’S DISEASE MARKET

FIGURE 9 GLOBAL: DERCUM’S DISEASE MARKET, BY TREATMENT, 2022 & 2032 (USD MILLION)

FIGURE 10 GLOBAL: DERCUM’S DISEASE MARKET, BY END-USER, 2022 & 2032 (USD MILLION)

FIGURE 11 GLOBAL: DERCUM’S DISEASE MARKET, BY DISTRIBUTIONCHANNEL, 2022 & 2032 (USD MILLION)

FIGURE 12 GLOBAL: DERCUM’S DISEASE MARKET, BY REGION 2022 & 2032 (USD MILLION)

FIGURE 13 GLOBAL: DERCUM’S DISEASE MARKET SHARE (%), BY REGION, 2022

FIGURE 14 NORTH AMERICA: DERCUM’S DISEASE MARKET, BY COUNTRY 2022 & 2032 (USD MILLION)

FIGURE 15 NORTH AMERICA: DERCUM’S DISEASE MARKET SHARE (%), BY COUNTRY 2022

FIGURE 16 EUROPE: DERCUM’S DISEASE MARKET, BY COUNTRY 2022 & 2032 (USD MILLION)

FIGURE 17 EUROPE: DERCUM’S DISEASE MARKET SHARE (%), BY COUNTRY 2022

FIGURE 18 ASIA PACIFIC DERCUM’S DISEASE MARKET SHARE, BY COUNTRY 2022 & 2032 (USD MILLION)

FIGURE 19 ASIA PACIFIC: DERCUM’S DISEASE MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 20 REST OF THE WORLD DERCUM’S DISEASE MARKET SHARE, BY REGION 2022 & 2032 (USD MILLION)

FIGURE 21 REST OF THE WORLD: DERCUM’S DISEASE MARKET SHARE (%), BY REGION, 2022

FIGURE 22 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 23 SALES (USD MILLION), 2022

FIGURE 24 R&D EXPENDITURE (USD MILLION), 2022

FIGURE 25 PFIZER INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 PFIZER INC: SWOT ANALYSIS

FIGURE 27 ABBVIE, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 JOHNSON & JOHNSON SERVICES, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 JOHNSON & JOHNSON SERVICES, INC.: SWOT ANALYSIS

FIGURE 30 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 GLAXOSMITHKLINE PLC: SWOT ANALYSIS

FIGURE 32 BAUSCH & LOMB INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 NIVARTA, INC: SWOT ANALYSIS

FIGURE 34 NOVARTIS INTERNATIONAL AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 NOVARTIS INTERNATIONAL AG: SWOT ANALYSIS